Literature DB >> 22633898

Fibronectin-binding nanoparticles for intracellular targeting addressed by B. burgdorferi BBK32 protein fragments.

Renate Ranka1, Ivars Petrovskis, Irina Sominskaya, Janis Bogans, Ruta Bruvere, Inara Akopjana, Velta Ose, Irena Timofejeva, Kalvis Brangulis, Pauls Pumpens, Viesturs Baumanis.   

Abstract

Virus-like particles (VLPs) are created by the self-assembly of multiple copies of envelope and/or capsid proteins from many viruses, mimicking the conformation of a native virus. Such noninfectious nanostructures are mainly used as antigen-presenting platforms, especially in vaccine research; however, some of them recently were used as scaffolds in biotechnology to produce targeted nanoparticles for intracellular delivery. This study demonstrates the creation of fusion VLPs using hepatitis B core protein-based system maintaining a fibronectin-binding property from B. burgdorferi BBK32 protein, including the evidence of particles' transmission to BHK-21 target cells via caveolae/rafts endocythosis. These results make this construct to be an attractive model in development of HBc-based nanoparticles for cellular targeting applications and highlights the fragment of B. burgdorferi BBK32 as a novel cellular uptake-promoting peptide. FROM THE CLINICAL EDITOR: This paper discusses the nanotechnology-based application of self-assembling viral-like peptides (VLP-s) for targeted delivery using a hepatitis B core protein based system. Creating fusion VLPs may be an attractive model for cellular targeting applications.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22633898     DOI: 10.1016/j.nano.2012.05.003

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  4 in total

1.  Distribution of hepatitis B virus genotypes in azerbaijani patients with chronic hepatitis B infection.

Authors:  Farah Bokharaei-Salim; Hossein Keyvani; Seyed Hamidreza Monavari; Maryam Esghaei; Shahin Fakhim; Angila Ataei Pirkooh; Bita Behnava
Journal:  Hepat Mon       Date:  2014-12-09       Impact factor: 0.660

2.  Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.

Authors:  Arnis Strods; Velta Ose; Janis Bogans; Indulis Cielens; Gints Kalnins; Ilze Radovica; Andris Kazaks; Paul Pumpens; Regina Renhofa
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

3.  Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses.

Authors:  Jaina M Patel; Min-Chul Kim; Vincent F Vartabedian; Yu-Na Lee; Sara He; Jae-Min Song; Hyo-Jick Choi; Satoshi Yamanaka; Nikhil Amaram; Anna Lukacher; Carlo D Montemagno; Richard W Compans; Sang-Moo Kang; Periasamy Selvaraj
Journal:  Nanomedicine       Date:  2015-03-06       Impact factor: 5.307

Review 4.  That's my story, and I'm sticking to it--an update on B. burgdorferi adhesins.

Authors:  Catherine A Brissette; Robert A Gaultney
Journal:  Front Cell Infect Microbiol       Date:  2014-04-03       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.